Globus Medical outlines 2026 non-GAAP EPS of $4.95-$5.05 while reaffirming $3.18B-$3.22B revenue (NYSE:GMED)
· seekingalpha.com
Globus Medical (GMED) Q2 2026 earnings call highlights: revenue, margin expansion, raised EPS guide, and key risks (Nevro, Enabling Tech).
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...